Aprea Therapeutics, Inc. SEC filings APRE
Aprea Therapeutics, Inc. has 446 filings in SEC EDGAR's recent list, going back to Jul 12, 2019. Its latest annual report, Form ARS, was filed on Apr 30, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 4, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 4, 2026 (results of operations, other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Results of operations, Other events
|
Nov 4, 2026 | Nov 4, 2026 |
| 8-K |
Current report
Other events
|
Aug 28, 2026 | Aug 28, 2026 |
| 8-K |
Current report
Results of operations, Other events
|
Aug 12, 2026 | Aug 12, 2026 |
| 8-K |
Current report
Listing notice
|
Jul 23, 2026 | Jul 23, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Jun 17, 2026 | Jun 16, 2026 |
| 8-K |
Current report
Results of operations, Other events
|
May 13, 2026 | May 13, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Apr 1, 2026 | Apr 1, 2026 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Regulation FD disclosure, Other events
|
Mar 30, 2026 | Mar 30, 2026 |
| 8-K |
Current report
Results of operations, Other events
|
Mar 16, 2026 | Mar 16, 2026 |
| 8-K |
Current report
Other events
|
Feb 18, 2026 | Feb 18, 2026 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Regulation FD disclosure, Other events
|
Jan 29, 2026 | Jan 28, 2026 |
| 8-K |
Current report
Listing notice
|
Jan 23, 2026 | Jan 23, 2026 |
| 8-K |
Current report
Other events
|
Jan 9, 2026 | Jan 9, 2026 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
|
Dec 9, 2025 | Dec 8, 2025 |
| 8-K |
Current report
Results of operations, Other events
|
Nov 12, 2025 | Nov 12, 2025 |
| 8-K |
Current report
Other events
|
Oct 24, 2025 | Oct 24, 2025 |
| 8-K |
Current report
Other events
|
Oct 15, 2025 | Oct 15, 2025 |
| 8-K |
Current report
Other events
|
Sep 8, 2025 | Sep 8, 2025 |
| 8-K |
Current report
Results of operations, Other events
|
Aug 12, 2025 | Aug 12, 2025 |
| 8-K |
Current report
Shareholder vote results
|
Jun 9, 2025 | Jun 5, 2025 |
| 8-K |
Current report
Results of operations, Other events
|
May 14, 2025 | May 14, 2025 |
| 8-K |
Current report
Results of operations, Officer or director change, Other events
|
Mar 25, 2025 | Mar 25, 2025 |
| 8-K |
Current report
Other events
|
Feb 5, 2025 | Feb 5, 2025 |
| 8-K |
Current report
Results of operations, Other events
|
Jan 13, 2025 | Jan 13, 2025 |
| 8-K |
Current report
Material agreement
|
Nov 8, 2024 | Nov 8, 2024 |
| 8-K |
Current report
Results of operations, Other events
|
Nov 7, 2024 | Nov 7, 2024 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Oct 23, 2024 | Oct 23, 2024 |
| 8-K |
Current report
Results of operations, Other events
|
Oct 9, 2024 | Oct 9, 2024 |
| 8-K |
Current report
Results of operations, Other events
|
Aug 12, 2024 | Aug 12, 2024 |
| 8-K |
Current report
Shareholder vote results
|
Jun 20, 2024 | Jun 20, 2024 |
| 8-K |
Current report
Other events
|
Jun 17, 2024 | Jun 17, 2024 |
| 8-K |
Current report
Results of operations, Other events
|
May 14, 2024 | May 14, 2024 |
| 8-K |
Current report
Other events
|
Apr 10, 2024 | Apr 10, 2024 |
| 8-K |
Current report
Results of operations, Other events
|
Mar 26, 2024 | Mar 26, 2024 |
| 8-K |
Current report
Material agreement, Agreement ended, Unregistered share sale, Regulation FD disclosure, Other events
|
Mar 12, 2024 | Mar 11, 2024 |
| 8-K |
Current report
Other events
|
Feb 6, 2024 | Feb 6, 2024 |
| 8-K |
Current report
Results of operations
|
Feb 2, 2024 | Feb 2, 2024 |
| 8-K |
Current report
Material agreement
|
Jan 26, 2024 | Jan 26, 2024 |
| 8-K |
Current report
Other events
|
Jan 4, 2024 | Jan 4, 2024 |
| 8-K |
Current report
Results of operations, Other events
|
Nov 9, 2023 | Nov 9, 2023 |
| 8-K |
Current report
Other events
|
Oct 16, 2023 | Oct 16, 2023 |
| 8-K |
Current report
Other events
|
Oct 13, 2023 | Oct 13, 2023 |
| 8-K |
Current report
Other events
|
Sep 11, 2023 | Sep 11, 2023 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Aug 24, 2023 | Aug 23, 2023 |
| 8-K |
Current report
Results of operations, Other events
|
Aug 10, 2023 | Aug 10, 2023 |
| 8-K |
Current report
Listing notice
|
Jul 5, 2023 | Jul 3, 2023 |
| 8-K |
Current report
Results of operations, Other events
|
May 15, 2023 | May 15, 2023 |
| 8-K |
Current report
Officer or director change, Other events
|
May 8, 2023 | May 5, 2023 |
| 8-K |
Current report
Auditor change
|
Apr 18, 2023 | Apr 17, 2023 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure, Other events
|
Mar 30, 2023 | Mar 30, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 13, 2023 | Mar 13, 2023 |
| 8-K |
Current report
Other events
|
Mar 1, 2023 | Mar 1, 2023 |
| 8-K |
Current report
Material agreement, Other events
|
Feb 24, 2023 | Feb 22, 2023 |
| 8-K |
Current report
Other events
|
Feb 14, 2023 | Feb 10, 2023 |
| 8-K |
Current report
Bylaw or fiscal year change, Regulation FD disclosure
|
Feb 13, 2023 | Feb 10, 2023 |
| 8-K |
Current report
Other events
|
Feb 10, 2023 | Feb 10, 2023 |
| 8-K |
Current report
Officer or director change, Other events
|
Jan 30, 2023 | Jan 30, 2023 |
| 8-K |
Current report
Other events
|
Jan 26, 2023 | Jan 26, 2023 |
| 8-K |
Current report
Other events
|
Jan 9, 2023 | Jan 9, 2023 |
| 8-K |
Current report
Shareholder vote results
|
Nov 17, 2022 | Nov 16, 2022 |
| 8-K |
Current report
Listing notice
|
Nov 16, 2022 | Nov 15, 2022 |
| 8-K |
Current report
Results of operations
|
Nov 9, 2022 | Nov 9, 2022 |
| 8-K |
Current report
Listing notice
|
Sep 16, 2022 | Sep 12, 2022 |
| 8-K |
Current report
Listing notice
|
Aug 19, 2022 | Aug 15, 2022 |
| 8-K |
Current report
Results of operations
|
Aug 11, 2022 | Aug 11, 2022 |
| 8-K |
Current report
Shareholder vote results
|
Aug 2, 2022 | Jul 28, 2022 |
| 8-K |
Current report
Listing notice
|
Jul 29, 2022 | Jul 28, 2022 |
| 8-K |
Current report
Listing notice
|
Jul 1, 2022 | Jun 29, 2022 |
| 8-K |
Current report
Material agreement, Acquisition or sale of assets, Listing notice, Unregistered share sale, Officer or director change, Bylaw or fiscal year change, Regulation FD disclosure
|
May 17, 2022 | May 16, 2022 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
May 16, 2022 | May 16, 2022 |
| 8-K |
Current report
Results of operations
|
Mar 15, 2022 | Mar 15, 2022 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Jan 13, 2022 | Jan 13, 2022 |
| 8-K |
Current report
Other events
|
Dec 9, 2021 | Dec 8, 2021 |
| 8-K |
Current report
Results of operations
|
Nov 8, 2021 | Nov 8, 2021 |
| 8-K |
Current report
Officer or director change
|
Oct 15, 2021 | Oct 13, 2021 |
| 8-K |
Current report
Results of operations, Other events
|
Aug 12, 2021 | Aug 11, 2021 |
| 8-K |
Current report
Other events
|
Aug 6, 2021 | Aug 4, 2021 |
| 8-K |
Current report
Shareholder vote results
|
Jun 10, 2021 | Jun 9, 2021 |
| 8-K |
Current report
Results of operations
|
May 6, 2021 | May 6, 2021 |
| 8-K |
Current report
Results of operations
|
Mar 16, 2021 | Mar 16, 2021 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Jan 12, 2021 | Jan 12, 2021 |
| 8-K |
Current report
Other events
|
Dec 28, 2020 | Dec 28, 2020 |
| 8-K |
Current report
Results of operations
|
Nov 5, 2020 | Nov 5, 2020 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Sep 29, 2020 | Sep 28, 2020 |
| 8-K |
Current report
Listing notice, Officer or director change, Regulation FD disclosure
|
Sep 18, 2020 | Sep 16, 2020 |
| 8-K |
Current report
Results of operations
|
Aug 11, 2020 | Aug 11, 2020 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Jun 29, 2020 | Jun 26, 2020 |
| 8-K |
Current report
Results of operations
|
May 15, 2020 | May 15, 2020 |
| 8-K |
Current report
Other events
|
Apr 3, 2020 | Apr 3, 2020 |
| 8-K |
Current report
Results of operations
|
Mar 26, 2020 | Mar 26, 2020 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Jan 13, 2020 | Jan 13, 2020 |
| 8-K |
Current report
Auditor change
|
Dec 16, 2019 | Dec 10, 2019 |
| 8-K |
Current report
Results of operations
|
Nov 14, 2019 | Nov 14, 2019 |
| 8-K |
Current report
Bylaw or fiscal year change
|
Oct 7, 2019 | Oct 7, 2019 |
Showing 94 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- APRE (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Doylestown, PA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1781983
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.